Government backs massive new £300m gene sequencing project

Experts believe entire population of Britain could benefit within a generation

Science Editor

England is poised to take a giant leap into the brave new world of genomic medicine, wherein everyone will eventually have their entire three billion letters of their genetic code unravelled in order to diagnose, treat and even predict future illnesses.

David Cameron said he is personally backing a research project to sequence 100,000 genomes of NHS patients in England by 2018, which some experts believe will become a national testbed for sequencing the genomes of the entire UK population within a generation.

However, the Government organisation behind the £300m initiative warned yesterday that people will have to be prepared to allow drug companies to have access to their genomic data, which the NHS is planning to make available to private industry under a commercial deal.

Genomics England, the wholly owned NHS company set up to run the project, said it is in discussions with drug companies and will try to enforce strict confidentiality of patient data. However, industry will need access to non-identifying details of peoples’ genomes in order to make advances in drugs and treatments, it said.

“If innovative treatments are to be found to extend or save lives then commercial companies will need to invest in the research, development and manufacture of new drugs and diagnostic tests,” Genomics England said.

“It has always been the case that this work is carried out in the commercial sector and not by Government or within the NHS itself,” it said.

Mr Cameron announced the 100,000 genomes project two years ago but yesterday he confirmed the financial arrangement that will see nearly £300m being poured into the initiative to build, equip and support a dedicated gene-sequencing facility in Cambridge.

“I am determined to do all I can to support the health and scientific sector to unlock the power of DNA, turning an important scientific breakthrough into something that will help deliver better tests, better drugs and above all better care for patients,” Mr Cameron said.

However, the Prime Minister made it clear that he also sees the initiative as an important stimulus for the UK economy, aided by the fact that the NHS holds enviable volumes of non-identifiable patient data that could be “mined” commercially by the private sector.

“As our plan becomes a reality, I believe we will be able to transform how devastating diseases are diagnosed and treated in the NHS and across the world, while supporting our best scientists and life-science businesses to discover the next wonder drug or breakthrough technology,” he said.

Although 100,000 genomes will be sequenced, only about 40,000 NHS patients will be involved. The parents of patients with rare diseases will also have their genomes sequenced, and NHS patients with cancer will have two genomes sequenced – the genome of their tumour and the genome of their healthy tissue.

The primary aim of the research project is to compare and contrast the genomes of people with rare illnesses or cancer in order to identify and understand the smallest DNA changes that are implicated in the onset, development or diagnosis of the condition.

A secondary element is to provide the doctors of the patients taking part with any genetic information that may be relevant to their care and treatment – but it is not yet designed to provide a risk assessment of future diseases, said Genomics England.

Jeremy Farrar, the director of the Wellcome Trust research charity, which has invested more than £1bn in genome research over the past 20 years, said that it is “inevitable” that everyone will eventually have their genome sequenced and that the genomic information will be used routinely by GPs and hospital doctors.

“Without this sort of project, which isn’t going on anywhere else in the world at this scale, you’re never going to know whether it’s worth [sequencing everyone’s genome],” Dr Farrar said.

“I think the public will demand it and the cost of doing it will be trivial, almost to the point of it being free. So I think it is inevitable in the working lives of young clinicians today that at some point in the future a GP will hold your whole genome,” he said.

The financial package to support the project involves Genomics England paying the American gene-sequencing company Illumina £78m in return for an investment by the firm of £162m over four years in genetic sequencing.

The Wellcome Trust will invest £27m in the new gene-sequencing facility on is Sanger Institute campus in Cambridge while the Medical Research Council will spend £24m on the “computing infrastructure” to collect, store and analyse the vast amounts of genomic data generated by the project.

Dr Farrar said: “Understanding humanity’s genetic code is not only going to be fundamental to the medicine of the future. It is an essential part of medicine today. In rare congenital diseases, in cancer and in infections, genomic insights are already transforming diagnosis and treatment.”

Q and A: Genomes

What is the 100,000 genomes project?

It is a Government-led initiative to sequence the full genetic code of about 40,000 NHS patients and their relatives. The patients fall into two main groups: those with rare diseases and those with cancer. The parents of patients with rare genetic diseases will also have their genomes sequenced, and patients with cancer will have two genomes sequenced – the genome of their tumour cells and the genome of their healthy cells – which brings the total to 100,000 genomes of about 75,000 people.

Why is this being done?

It is primarily a research project to tease out the minute changes in the DNA of the human genome that are involved in some way with the onset or development of disease. By studying many thousands of genomes, and comparing their detailed genetic sequences, scientists hope to pinpoint mutations or DNA “polymorphisms” that could lead to a greater understanding of the condition. Eventually this will lead to better diagnostic tests, drugs and treatments.

Who is doing it?

The Government has established a company called Genomics England, which is wholly owned by the NHS, to run the project. It is working closely with the Medical Research Council and the Wellcome Trust, the medical research charity that co-funded much of the initial work that led to the first human genome being sequenced in 2003. The pharmaceutical industry is also being invited to take part and it will have access to non-identifiable genome data under special licences or order to develop new products.

Can anyone take part?

Children with rare genetic diseases, and their families, as well as cancer patients will be invited to take part. At least 80 per cent of rare diseases have a genomic basis, which is why studying the DNA of these children and their families should help to point to new treatments for these devastating conditions. Similarly, cancer is fundamentally a genetic disease – although not always inherited – because it results from changes to a person’s DNA that can trigger healthy cells to become tumours.

How confidential is the genome data?

Genomics England emphasises that it will take every precaution to protect patient confidentiality. Raw genome data will not be taken away from its computers and a patient’s identifying details will be encoded to ensure anonymity. However, participants will be told that they must be willing for commercial companies to conduct research on their anonymised data.

Genome sequencing - how it works

Sequencing the human genome is another way of saying that the genetic code of the DNA molecule is “read” letter by letter, until all three billion letters are written down in the right order.

Today this process is done by machines and computers that can automatically break up the DNA molecule into smaller, manageable fragments which are then sequenced several times to ensure accuracy.

The patient only has to supply a blood or tissue sample and scientists then isolate the DNA within the cells before putting it into the gene-sequencing machines.

Originally it took many years and many hundreds of millions of pounds to sequence a full genome, but now it can be done in a few days for less than £1,000.

Now, gene sequencing has become a relatively straightforward procedure and is getting cheaper and faster.  The real difficulty lies in making sense of the genomic information, and in designing software that can see patterns in the DNA that are too complex for the human eye.

Food blogger and Guardian writer Jack Monroe with her young son
peopleSinger tells The Independent what life is like in rehab in an exclusive video interview
Arts and Entertainment
booksPhotographer Richard Young has been snapping celebrities at play for 40 years - but he says it wasn’t all fun and games...
Life and Style
ebookNow available in paperback
Life and Style
ebooksA superb mix of recipes serving up the freshest of local produce in a delicious range of styles
Aguero - who single-handedly has kept City's Champions League dreams alive - celebrates his dramatic late winner
footballManchester City 3 Bayern Munich 2: Argentine's late hat-rick sees home side snatch vital victory
Muhammad Ali pictured in better health in 2006
peopleBut he has enjoyed publicity from his alleged near-death experience
Arts and Entertainment
Tony breaks into Ian Garrett's yacht and makes a shocking discovery
TVReview: Revelations continue to make this drama a tough watch
Arts and Entertainment
The assumption that women are not as competent in leadership positions as men are leads to increased stress in the workplace
science... and it's down to gender stereotypes
Life and Style
The racy marketing to entice consumers to buy Fairlife, which launches in the US next month
food + drink
Arts and Entertainment
Inner sanctum: Tove Jansson and friends in her studio in 1992
booksWhat was the inspiration for Finland's most famous family?
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Austen Lloyd: Commercial Property Lawyer - Cheshire

    Excellent Salary: Austen Lloyd: CHESHIRE MARKET TOWN - An exciting and rare o...

    Austen Lloyd: Residential Property Solicitor - Hampshire

    Excellent Salary : Austen Lloyd: NORTH HAMPSHIRE - SENIOR POSITION - An exciti...

    Recruitment Genius: Gas Installation Engineer

    £29000 per annum: Recruitment Genius: A Gas Installation Engineer is required ...

    Recruitment Genius: Domestic Gas Technical Surveyor

    £28000 per annum: Recruitment Genius: A Domestic Gas Technical Surveyor is req...

    Day In a Page

    Homeless Veterans Christmas Appeal: Drifting and forgotten - turning lives around for ex-soldiers

    Homeless Veterans Christmas Appeal: Turning lives around for ex-soldiers

    Our partner charities help veterans on the brink – and get them back on their feet
    Putin’s far-right ambition: Think-tank reveals how Russian President is wooing – and funding – populist parties across Europe to gain influence in the EU

    Putin’s far-right ambition

    Think-tank reveals how Russian President is wooing – and funding – populist parties across Europe to gain influence in the EU
    Tove Jansson's Moominland: What was the inspiration for Finland's most famous family?

    Escape to Moominland

    What was the inspiration for Finland's most famous family?
    Nightclubbing with Richard Young: The story behind his latest book of celebrity photographs

    24-Hour party person

    Photographer Richard Young has been snapping celebrities at play for 40 years. As his latest book is released, he reveals that it wasn’t all fun and games
    Michelle Obama's school dinners: America’s children have a message for the First Lady

    A taste for rebellion

    US children have started an online protest against Michelle Obama’s drive for healthy school meals by posting photos of their lunches
    Colouring books for adults: How the French are going crazy for Crayolas

    Colouring books for adults

    How the French are going crazy for Crayolas
    Jack Thorne's play 'Hope': What would you do as a local politician faced with an impossible choice of cuts?

    What would you do as a local politician faced with an impossible choice of cuts?

    Playwright Jack Thorne's latest work 'Hope' poses the question to audiences
    Ed Harcourt on Romeo Beckham and life as a court composer at Burberry

    Call me Ed Mozart

    Paloma Faith, Lana del Ray... Romeo Beckham. Ed Harcourt has proved that he can write for them all. But it took a personal crisis to turn him from indie star to writer-for-hire
    10 best stocking fillers for foodies

    Festive treats: 10 best stocking fillers for foodies

    From boozy milk to wasabi, give the food-lover in your life some extra-special, unusual treats to wake up to on Christmas morning
    Phil Hughes head injury: He had one weakness – it has come back to haunt him

    Phil Hughes had one weakness – it has come back to haunt him

    Prolific opener had world at his feet until Harmison and Flintoff bounced him
    'I have an age of attraction that starts as low as four': How do you deal with a paedophile who has never committed a crime?

    'I am a paedophile'

    Is our approach to sex offenders helping to create more victims?
    How bad do you have to be to lose a Home Office contract?

    How bad do you have to be to lose a Home Office contract?

    Serco given Yarl’s Wood immigration contract despite ‘vast failings’
    Green Party on the march in Bristol: From a lost deposit to victory

    From a lost deposit to victory

    Green Party on the march in Bristol
    Putting the grot right into Santa's grotto

    Winter blunderlands

    Putting the grot into grotto
    'It just came to us, why not do it naked?' London's first nude free runner captured in breathtaking images across capital

    'It just came to us, why not do it naked?'

    London's first nude free runner captured in breathtaking images across capital